Exchange & Returns Information
Review Details
(75)
| Generic For | TOPAMAX |
|---|---|
| Active Ingredient | TOPIRAMATE |
| Strength | 50MG |
| Manufacturer | JOHNLEE PHARMACEUTICALS |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| 1 BOX - 100 TABLETS | $ 0.31 | $ 30.90 |
$ 26.27
Apply ZARVY26 (-15%)
You save $ 4.64
|
||
| 2 BOXES - 200 TABLETS | $ 0.33 | $ 66.90 |
$ 56.87
Apply ZARVY26 (-15%)
You save $ 10.04
|
||
| ★ Best Value 3 BOXES - 300 TABLETS | $ 0.34 | $ 100.90 |
$ 85.77
Apply ZARVY26 (-15%)
You save $ 15.14
|
Reference information will be available soon.
Leemate 50 is a 50mg oral tablet formulation of topiramate, a clinically proven anticonvulsant with broad applications in neurological and behavioral medicine. Its primary mechanisms involve modulation of neurotransmitters and stabilization of neuronal firing, making it effective for both seizure control and migraine prevention. Beyond its on-label uses, topiramate is increasingly used off-label to support smoking cessation, particularly in individuals with comorbid alcohol use or impulse control disorders. By dampening the brain's dopamine-driven reward system, it reduces cravings and enhances self-regulatory capacity during nicotine withdrawal.
- Sleep & Mental Health > Epilepsy Topiramate is approved for the treatment of partial-onset seizures and primary generalized tonic-clonic (GTC) seizures. It is also effective as adjunct therapy for complex epilepsy syndromes such as Lennox-Gastaut. Its multi-modal action reduces neuronal excitability and seizure propagation, making it a reliable option for chronic seizure prevention across age groups. - Painkillers & Headache > Migraine Used as a preventive therapy, topiramate helps reduce the frequency, duration, and severity of migraine episodes. It does not treat acute attacks but plays a key role in long-term management by inhibiting cortical spreading depression and stabilizing trigeminal nerve pathways involved in pain transmission. - Smoking Cessation Treatment > Others (off-label cognitive impulse modulation) Topiramate has shown promise in smoking cessation through its effect on the mesolimbic dopamine system. It helps reduce reward-driven nicotine cravings and improves abstinence rates in patients who have not responded to standard treatments such as nicotine patches or varenicline. This off-label use is especially helpful for individuals with impulsivity, mood instability, or substance use histories.
Topiramate’s therapeutic efficacy is derived from multiple neurophysiological actions: it enhances inhibitory GABAergic transmission, inhibits excitatory glutamatergic pathways (AMPA/kainate receptors), blocks voltage-sensitive sodium channels, and weakly inhibits carbonic anhydrase. These combined actions contribute to a reduction in excessive neuronal firing, stabilize brain circuits, and promote cognitive balance. These properties not only suppress seizures and migraines but also modulate impulsive behaviors—making it suitable for addiction-related interventions like smoking cessation.
Topiramate must be titrated gradually to reduce cognitive and metabolic side effects, especially when used for off-label indications. → Epilepsy - Monotherapy (Immediate-Release): • Week 1: 25 mg twice daily • Titrate weekly to 200 mg twice daily (400 mg/day) by Week 6 - Monotherapy (Extended-Release): • Week 1: 50 mg once daily • Titrate weekly to 400 mg once daily by Week 6 - Adjunctive Therapy (Immediate-Release): • Start: 25–50 mg once daily • Increase weekly to 200–400 mg/day in 2 divided doses - Adjunctive Therapy (Extended-Release): • Start: 25–50 mg once daily • Increase weekly to 200–400 mg once daily → Migraine Prophylaxis - Immediate-Release: • Week 1: 25 mg at bedtime • Titrate weekly to 50 mg twice daily (100 mg/day) by Week 4 - Extended-Release: • Week 1: 25 mg once daily • Increase weekly to 100 mg once daily by Week 4 → Lennox-Gastaut Syndrome (Adjunct): - Immediate or Extended-Release: • Start: 25–50 mg/day • Increase weekly to 200–400 mg/day in 1 or 2 divided doses → Smoking Cessation (Off-label Use): - Week 1: 25 mg once daily (preferably at bedtime) - Week 2: 50 mg once daily - Week 3: 75 mg once daily - Week 4: 100 mg once daily - Week 5: 150 mg once daily - Week 6: 200 mg once daily - Week 7–8: Up to 300 mg once daily based on response and tolerability → Duration: Typical course is 8 to 12 weeks. Extended use is considered based on patient progress. → Administration: Take once daily, with or without food. Bedtime use is recommended to minimize sedation or attention deficits. → Combination Therapy: When used with bupropion or nicotine replacement therapies, monitor closely for additive CNS side effects or mood fluctuations. → Discontinuation: Taper gradually to prevent rebound seizures, especially in patients with a seizure history.
Store in a dry and cool location away from sunlight and humidity. Maintain temperature below 25°C. Ensure the bottle is closed tightly after each use. Keep out of reach of children.
Common: drowsiness, dizziness, cognitive slowing, paresthesia, decreased appetite Less common: language difficulties, kidney stones, taste changes, mood swings Serious: depression, suicidal ideation, visual field defects, metabolic acidosis Medical supervision is advised if significant mood changes, vision problems, or confusion occur.
Felt professional and trustworthy.
Had a good experience all around.
Website is clean and easy to use.
Will continue to order from here.
Still just as good.
No combo deals available at the moment.
